But the really impressive numbers came from the SURPASS-5 trial, where tirzepatide reduced total cholesterol by 12.9%, LDL cholesterol by 15.5%, and triglycerides by a substantial 24.9%, while increasing HDL cholesterol by 0.9%
The inhaled silica particles can be directly phagocytosed by alveolar macrophages (AMs), and thereby triggers NLRP3 inflammasome activation and IL-1 production, which results in a cascade release of proinflammatory and profibrotic cytokines, i.e., IL-6, tumor necrosis factor (TNF-) and TGF-1
Overlap or Transition Timing : - Depending on the patient's glycemic control, some physicians recommend a 1-2 week overlap or direct switch, ensuring no gap in treatment
AI algorithms need to be trained on high-quality, unbiased real-world datasets that include diverse data representative of the overall patient population
A post hoc analysis of that trial found that 82% of tirzepatide-treated participants had already lost 5% or more of their body weight by week 12
10.1021/acs.jafc.8b00829 137 ZhouK.DonnellyL
.png)
